Published in Cancer on March 01, 1992
Screening for prostate cancer. West J Med (1995) 1.12
Prostate-specific antigen testing accuracy in community practice. BMC Fam Pract (2002) 0.92
PSA screening: the bottom line. CMAJ (2000) 0.84
Lifetime total and beverage specific--alcohol intake and prostate cancer risk: a case-control study. Nutr J (2004) 0.84
Imaging in genitourinary cancer from the urologists' perspective. Cancer Imaging (2007) 0.76
Are hypoechoic lesions on transrectal ultrasonography a marker for clinically significant prostate cancer? Korean J Urol (2013) 0.75
Potential clinical importance of the activation peptide of prostate-specific antigen. Int J Clin Exp Pathol (2009) 0.75
Controversy in clinical cancer screening--prostate-specific antigen. West J Med (1994) 0.75
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell (1979) 12.83
Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell (1997) 11.35
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet (1983) 8.94
'Green revolution' genes encode mutant gibberellin response modulators. Nature (1999) 8.87
Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids. Nature (1981) 8.66
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol (1988) 8.09
The Arabidopsis GAI gene defines a signaling pathway that negatively regulates gibberellin responses. Genes Dev (1997) 7.30
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sci U S A (1986) 6.16
Transcription termination at the trp operon attenuators of Escherichia coli and Salmonella typhimurium: RNA secondary structure and regulation of termination. Proc Natl Acad Sci U S A (1977) 6.08
Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells. Proc Natl Acad Sci U S A (1984) 5.81
New features of the regulation of the tryptophan operon. Science (1975) 5.40
Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem (1990) 5.36
High-efficiency cloning of full-length cDNA; construction and screening of cDNA expression libraries for mammalian cells. Methods Enzymol (1987) 5.08
Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci U S A (1986) 4.59
Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells. Proc Natl Acad Sci U S A (1985) 3.95
RNA polymerase interaction at the promoter--operator region of the tryptophan operon of Escherichia coli and Salmonella typhimurium. J Mol Biol (1978) 3.84
Nucleotide sequence of the 5' end of tryptophan messenger RNA of Escherichia coli. J Mol Biol (1976) 3.60
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer (1980) 3.37
Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells. Proc Natl Acad Sci U S A (1985) 3.31
Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med (1989) 3.28
Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med (1987) 3.22
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J (1985) 3.04
Comparison of the nucleotide sequences of the initial transcribed regions of the tryptophan operons of Escherichia coli and Salmonella typhimurium. J Mol Biol (1978) 2.86
Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun (1995) 2.80
Systematic biases in functional status assessment of elderly adults: effects of different data sources. J Gerontol (1984) 2.77
Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg (1987) 2.58
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell (1983) 2.54
Management of peritoneal tear during endoscopic extraperitoneal inguinal hernioplasty. Surg Endosc (2002) 2.52
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin (1993) 2.43
Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells. Proc Natl Acad Sci U S A (1988) 2.37
Structure of the chromosomal gene for murine interleukin 3. Proc Natl Acad Sci U S A (1985) 2.33
B cell growth-promoting activity of recombinant human interleukin 4. J Immunol (1987) 2.31
A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells. Cell (1987) 2.27
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores. J Am Acad Child Adolesc Psychiatry (1994) 2.14
Recombinant interleukin 4 promotes the growth of human T cells. J Immunol (1987) 2.13
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med (2000) 2.10
IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol (1989) 2.10
What young men know about testicular cancer. Prev Med (1983) 2.08
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Termination of transcription in vitro in the Escherichia coli tryptophan operon leader region. J Mol Biol (1976) 1.99
Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells. Blood (1993) 1.99
The attenuator of the tryptophan operon of Escherichia coli. Heterogeneous 3'-OH termini in vivo and deletion mapping of functions. J Mol Biol (1977) 1.93
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology (1988) 1.83
Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation (1994) 1.79
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Commission on Cancer. J Urol (1994) 1.75
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Control of hemopoiesis by a bone marrow stromal cell clone: lipopolysaccharide- and interleukin-1-inducible production of colony-stimulating factors. Blood (1987) 1.72
The future need for geriatric manpower in the United States. N Engl J Med (1980) 1.72
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
Structural analysis of the mouse chromosomal gene encoding interleukin 4 which expresses B cell, T cell and mast cell stimulating activities. Nucleic Acids Res (1987) 1.70
GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. Mol Biol Cell (2001) 1.65
National survey of patterns of care for brain-tumor patients. J Neurosurg (1989) 1.64
Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol (1999) 1.64
Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem (1989) 1.60
Secondary carcinomas of the kidney. J Urol (1975) 1.59
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58
Trends in teenage pregnancy in England and Wales: how can we explain them? J R Soc Med (1999) 1.58
Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58
Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells. J Mol Appl Genet (1981) 1.56
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
Functional analysis of the steroid hormone control region of mouse mammary tumor virus. Nucleic Acids Res (1984) 1.54
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J Gen Microbiol (1992) 1.48
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer (1997) 1.47
Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am (1992) 1.47
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.46
The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease. Int J Geriatr Psychiatry (1997) 1.46
Detection of antibodies to herpes simplex virus in the cerebrospinal fluid of patients with herpes simplex encephalitis. J Infect Dis (1987) 1.43
The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care (2002) 1.43
Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer. J Urol (1989) 1.42
Regulation of skeletal muscle glycogen phosphorylase and PDH during maximal intermittent exercise. Am J Physiol (1999) 1.41
SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol (1998) 1.41
Use of esophagectomy to treat recurrent hyperplastic tissue obstruction caused by multiple metallic stent insertion for corrosive stricture. Endoscopy (2000) 1.41
[Total cystectomies for cancers locally advanced of bladder about 12 cases in the service of urology of the general hospital of Grand-Yoff]. Prog Urol (2010) 1.40
The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer (1991) 1.39
The outcome of hospitalization for acute illness in the elderly. J Am Geriatr Soc (1983) 1.38
An evaluation of rural health care research. Eval Q (1979) 1.35
Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer (1988) 1.35
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses. Dev Immunol (1998) 1.33
Medical students' attitudes toward rural practice. J Med Educ (1973) 1.33
Dietary risk factors in human bladder cancer. Am J Epidemiol (1979) 1.33
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci U S A (1997) 1.33